NNovo Nordisk Read More Ozempic, Zepbound and other GLP-1 drugs face new US eye risk warnings2026-11-10 European regulators previously identified similar concerns The US decision follows an earlier assessment by the European Medicines…
NNovo Nordisk Read More Novo Nordisk and Hims End Their Ozempic War. Here’s What It Means for You2026-03-09 A war between some of the biggest names in weight loss has abruptly ended in a mutually beneficial…
NNovo Nordisk Read More Novo Nordisk taps start-up for new oral weight-loss drugs2026-02-28 Fresh off the launch of its semaglutide pill, Novo Nordisk has entered a partnership with a start-up…
NNovo Nordisk Read More Novo Nordisk Commits Up to $2B to Drug Delivery Startup Vivtex for R&D of Oral Metabolic Meds2026-02-25 The intestinal wall is like a gatekeeper, absorbing certain compounds while keeping others from passing through. To the…